다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

홈
인베스팅
주식
미국
NASDAQ
CASI Pharmaceuticals Inc (CASI)
CASI Pharmaceuticals Inc (CASI) 뉴스

CASI

CASI Pharmaceuticals (CASI)

CASI Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CASI

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/09/12	20:30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CASI	CASI Pharmaceuticals Inc
2024/09/04	21:00	PR Newswire (US)	CASI PHARMACEUTICALS TO PARTICIPATE IN THE 2024 H.C. WAINWRIGHT GLOBAL INVESTMENT CONFERENCE	NASDAQ:CASI	CASI Pharmaceuticals Inc
2024/09/04	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:CASI	CASI Pharmaceuticals Inc
2024/08/29	21:00	Edgar (US Regulatory)	Form F-3/A - Registration statement by foreign private issuers: [Amend]	NASDAQ:CASI	CASI Pharmaceuticals Inc
2024/08/17	06:01	Edgar (US Regulatory)	Form F-3 - Registration statement by foreign private issuers	NASDAQ:CASI	CASI Pharmaceuticals Inc
2024/08/16	21:30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CASI	CASI Pharmaceuticals Inc
2024/08/16	21:00	PR Newswire (US)	CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2024 BUSINESS AND FINANCIAL RESULTS	NASDAQ:CASI	CASI Pharmaceuticals Inc
2024/08/14	19:18	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:CASI	CASI Pharmaceuticals Inc
2024/07/20	06:30	PR Newswire (US)	CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS	NASDAQ:CASI	CASI Pharmaceuticals Inc
2024/07/19	19:07	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CASI	CASI Pharmaceuticals Inc
2024/07/16	05:01	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:CASI	CASI Pharmaceuticals Inc
2024/07/08	20:48	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CASI	CASI Pharmaceuticals Inc
2024/07/08	20:30	PR Newswire (US)	CASI Pharmaceuticals announces appointment of Daniel Lang, MD as CFO and SVP	NASDAQ:CASI	CASI Pharmaceuticals Inc
2024/06/27	05:15	PR Newswire (US)	CASI Pharmaceuticals Announces Plan To Submit IND Application For CID-103, an Anti-CD 38 Antibody in Antibody-Mediated Rejection, and Receipt of a Non-Binding Proposal to Acquire Entire China Business of the Company	NASDAQ:CASI	CASI Pharmaceuticals Inc
2024/06/27	05:10	PR Newswire (US)	CASI Pharmaceuticals Announces $15 Million Private Placement Financing by Venrock Healthcare Capital Partners, Foresite Capital, Panacea Venture and Dr. Wei-Wu He	NASDAQ:CASI	CASI Pharmaceuticals Inc
2024/05/15	21:00	PR Newswire (US)	CASI Pharmaceuticals Receives FDA Clearance On The Investigational New Drug (IND) Application For CID-103 In Immune Thrombocytopenia (ITP)	NASDAQ:CASI	CASI Pharmaceuticals Inc
2024/05/15	19:50	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CASI	CASI Pharmaceuticals Inc
2024/05/14	21:00	PR Newswire (US)	CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2024 BUSINESS AND FINANCIAL RESULTS	NASDAQ:CASI	CASI Pharmaceuticals Inc
2024/05/13	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:CASI	CASI Pharmaceuticals Inc
2024/04/09	06:00	PR Newswire (US)	CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS	NASDAQ:CASI	CASI Pharmaceuticals Inc
2024/03/28	20:00	PR Newswire (US)	CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 BUSINESS AND FINANCIAL RESULTS	NASDAQ:CASI	CASI Pharmaceuticals Inc
2024/03/05	21:00	PR Newswire (US)	CASI Pharmaceuticals Report Positive Interim Phase 1 Data For BI-1206 In The Treatment Of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma In China	NASDAQ:CASI	CASI Pharmaceuticals Inc
2024/02/16	21:00	PR Newswire (US)	CASI PHARMACEUTICALS ANNOUNCES FIRST DOSING OF FOLOTYN® IN CHINA	NASDAQ:CASI	CASI Pharmaceuticals Inc
2023/11/14	21:00	PR Newswire (US)	CASI PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2023 BUSINESS AND FINANCIAL UPDATES	NASDAQ:CASI	CASI Pharmaceuticals Inc
2023/11/08	21:00	PR Newswire (US)	CASI PHARMACEUTICALS ANNOUNCES MARKET APPROVAL OF CNCT19 BY CHINA NMPA	NASDAQ:CASI	CASI Pharmaceuticals Inc
2023/08/11	20:00	PR Newswire (US)	CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2023 BUSINESS AND FINANCIAL UPDATES	NASDAQ:CASI	CASI Pharmaceuticals Inc
2023/08/01	20:00	PR Newswire (US)	Mundipharma International Corporation Limited, Mundipharma Medical Company, and Acrotech Biopharma Inc. Enter Agreement to Transfer License of FOLOTYN® (Pralatrexate) in China to CASI Pharmaceuticals	NASDAQ:CASI	CASI Pharmaceuticals Inc
2023/07/20	21:00	PR Newswire (US)	CASI Pharmaceuticals Acquires Global Intellectual Property Rights to Cleave Therapeutics' VCP/P97 Inhibitor CB-5339	NASDAQ:CASI	CASI Pharmaceuticals Inc
2023/05/17	20:35	PR Newswire (US)	CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS	NASDAQ:CASI	CASI Pharmaceuticals Inc
2023/04/26	22:49	PR Newswire (US)	CASI Pharmaceuticals Files Annual Report on Form 20-F for Fiscal Year 2022	NASDAQ:CASI	CASI Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:CASI

1 2 3 4 5 6 7 8 9 10 다음 >>

Deutsche Telekom (QX)

Gold vs US Dollar

Invesco QQQ Trust Series 1

Energy Select Sector SPDR

Financial Select Sector

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관